Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Petri

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The CRISPR Journal|April 26, 2019
SHERLOCK and DETECTR Open a New Frontier in Molecular DiagnosticsKarl Petri, Vikram Pattanayak
Frontiers in Immunology|March 23, 2026
Editorial: Safety and efficacy of CRISPR/Cas-based genome editing tools: applications and considerations in cell and gene therapyKarl Petri, Samuele Ferrari, Beatrice Claudia Cianciotti
Nature Reviews. Clinical Oncology|September 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunitiesKarl Petri, Elvira D'Ippolito, Annette Künkele, et al.
Biotechniques|May 9, 2014
Comparative next-generation sequencing of adeno-associated virus inverted terminal repeatsKarl Petri, Raffaele Fronza, Richard Gabriel, et al.
Elife|June 7, 2024
Enhancing CRISPR prime editing by reducing misfolded pegRNA interactionsWeiting Zhang, Karl Petri, Junyan Ma, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Enhancing CRISPR prime editing by reducing misfolded pegRNA interactionsWeiting Zhang, Karl Petri, Junyan Ma, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor ModificationFriederike Knipping, Mark J Osborn, Karl Petri, et al.
Journal of Virology|May 15, 2015
Presence of a trs-Like Motif Promotes Rep-Mediated Wild-Type Adeno-Associated Virus Type 2 IntegrationKarl Petri, Richard Gabriel, Leticia Agundez, et al.
Nature Biotechnology|September 27, 2022
Engineered CRISPR prime editors with compact, untethered reverse transcriptasesJulian Grünewald, Bret R Miller, Regan N Szalay, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquitoWilliam T Garrood, Nace Kranjc, Karl Petri, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The CRISPR Journal|April 26, 2019
SHERLOCK and DETECTR Open a New Frontier in Molecular DiagnosticsKarl Petri, Vikram Pattanayak
Frontiers in Immunology|March 23, 2026
Editorial: Safety and efficacy of CRISPR/Cas-based genome editing tools: applications and considerations in cell and gene therapyKarl Petri, Samuele Ferrari, Beatrice Claudia Cianciotti
Nature Reviews. Clinical Oncology|September 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunitiesKarl Petri, Elvira D'Ippolito, Annette Künkele, et al.
Biotechniques|May 9, 2014
Comparative next-generation sequencing of adeno-associated virus inverted terminal repeatsKarl Petri, Raffaele Fronza, Richard Gabriel, et al.
Elife|June 7, 2024
Enhancing CRISPR prime editing by reducing misfolded pegRNA interactionsWeiting Zhang, Karl Petri, Junyan Ma, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Enhancing CRISPR prime editing by reducing misfolded pegRNA interactionsWeiting Zhang, Karl Petri, Junyan Ma, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor ModificationFriederike Knipping, Mark J Osborn, Karl Petri, et al.
Journal of Virology|May 15, 2015
Presence of a trs-Like Motif Promotes Rep-Mediated Wild-Type Adeno-Associated Virus Type 2 IntegrationKarl Petri, Richard Gabriel, Leticia Agundez, et al.
Nature Biotechnology|September 27, 2022
Engineered CRISPR prime editors with compact, untethered reverse transcriptasesJulian Grünewald, Bret R Miller, Regan N Szalay, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquitoWilliam T Garrood, Nace Kranjc, Karl Petri, et al.
Pageof 2